PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,010,106 | -15.0% | 180,462 | +40.8% | 0.02% | -8.0% |
| Q2 2023 | $3,540,801 | +35.8% | 128,197 | +13.1% | 0.02% | +25.0% |
| Q1 2023 | $2,607,165 | -0.7% | 113,355 | -52.9% | 0.02% | 0.0% |
| Q4 2022 | $2,626,528 | +28.2% | 240,745 | -0.9% | 0.02% | +17.6% |
| Q3 2022 | $2,049,000 | +125.7% | 243,013 | +111.8% | 0.02% | +142.9% |
| Q2 2022 | $908,000 | -68.0% | 114,759 | -4.2% | 0.01% | -61.1% |
| Q1 2022 | $2,838,000 | -30.1% | 119,834 | +0.9% | 0.02% | -30.8% |
| Q4 2021 | $4,060,000 | +221.2% | 118,715 | +66.4% | 0.03% | +188.9% |
| Q3 2021 | $1,264,000 | -76.4% | 71,343 | -40.2% | 0.01% | -74.3% |
| Q2 2021 | $5,358,000 | – | 119,391 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,446,874 | $154,696,000 | 18.62% |
| Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $109,919,000 | 11.24% |
| BVF INC/IL | 3,754,095 | $168,484,000 | 6.32% |
| Tri Locum Partners LP | 341,650 | $15,333,000 | 5.02% |
| Twin Lakes Capital Management, LLC | 143,440 | $6,438,000 | 3.58% |
| COMMODORE CAPITAL LP | 210,600 | $9,452,000 | 3.29% |
| Altium Capital Management LP | 282,445 | $12,676,000 | 2.94% |
| Pinz Capital Management, LP | 196,000 | $8,796,000 | 2.65% |
| Opaleye Management Inc. | 330,222 | $14,820,000 | 2.46% |
| RTW INVESTMENTS, LP | 3,507,390 | $157,412,000 | 2.38% |